J. Ayllón

784 total citations
22 papers, 567 citations indexed

About

J. Ayllón is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, J. Ayllón has authored 22 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 7 papers in Oncology. Recurrent topics in J. Ayllón's work include Renal cell carcinoma treatment (8 papers), Renal and related cancers (4 papers) and Prostate Cancer Treatment and Research (4 papers). J. Ayllón is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Renal and related cancers (4 papers) and Prostate Cancer Treatment and Research (4 papers). J. Ayllón collaborates with scholars based in France, Spain and Belgium. J. Ayllón's co-authors include Juan Mompeán, Pascual Parrilla Paricio, Ricardo Robles Campos, Javier Tébar, Juan Riquelme, José Luis Aguayo Albasini, Stéphane Oudard, Jacques Médioni, Eduardo Barrascout and Benoit Beuselinck and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

J. Ayllón

22 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Ayllón France 10 354 260 144 113 81 22 567
Che‐Jen Huang Taiwan 14 281 0.8× 96 0.4× 156 1.1× 35 0.3× 42 0.5× 38 458
Samuel P. Bugis Canada 15 395 1.1× 63 0.2× 120 0.8× 84 0.7× 54 0.7× 23 634
Jean‐François Egger Switzerland 10 173 0.5× 72 0.3× 114 0.8× 33 0.3× 54 0.7× 14 374
Ioannis Kyriazanos Greece 12 247 0.7× 142 0.5× 80 0.6× 44 0.4× 100 1.2× 26 438
Kiichi Sugimoto Japan 11 199 0.6× 101 0.4× 190 1.3× 15 0.1× 42 0.5× 104 415
Glen W. Barrisford United States 12 191 0.5× 202 0.8× 105 0.7× 24 0.2× 118 1.5× 16 490
Reed I. Ayabe United States 12 174 0.5× 107 0.4× 144 1.0× 38 0.3× 38 0.5× 40 436
Eung Jin Shin South Korea 13 307 0.9× 141 0.5× 190 1.3× 62 0.5× 31 0.4× 34 490
Jae Huh United States 11 852 2.4× 152 0.6× 152 1.1× 40 0.4× 39 0.5× 14 1.2k
T. D’Amico Italy 12 149 0.4× 213 0.8× 69 0.5× 15 0.1× 58 0.7× 36 420

Countries citing papers authored by J. Ayllón

Since Specialization
Citations

This map shows the geographic impact of J. Ayllón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ayllón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ayllón more than expected).

Fields of papers citing papers by J. Ayllón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ayllón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ayllón. The network helps show where J. Ayllón may publish in the future.

Co-authorship network of co-authors of J. Ayllón

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ayllón. A scholar is included among the top collaborators of J. Ayllón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ayllón. J. Ayllón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayllón, J., Virginie Verkarre, Florian Scotté, et al.. (2012). Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma. American Journal of Case Reports. 13. 38–40. 5 indexed citations
2.
Barrascout, Eduardo, et al.. (2012). Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumab: a case report. American Journal of Case Reports. 13. 1–2. 12 indexed citations
5.
Barrascout, Eduardo, Jacques Médioni, Florian Scotté, et al.. (2010). Inhibiteurs de l’angiogenèse : revues de l’apport thérapeutique du sorafenib, du sunitinib et du bevacizumab dans le cancer du rein métastatique. Bulletin du Cancer. 97(2). S29–S43. 15 indexed citations
6.
Ayllón, J. & G. Pignot. (2010). Risque hémorragique et anti-angiogéniques. Progrès en Urologie. 20. S20–S22. 1 indexed citations
7.
Beuselinck, Benoit, Stéphane Oudard, Olivier Rixe, et al.. (2010). Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Annals of Oncology. 22(4). 794–800. 115 indexed citations
8.
Launay‐Vacher, Vincent, J. Ayllón, Nicolas Janus, et al.. (2009). Drug Management of Prostate Cancer: Prevalence and Consequences of Renal Insufficiency. Clinical Genitourinary Cancer. 7(3). E83–E89. 23 indexed citations
9.
Launay‐Vacher, Vincent, J. Ayllón, Nicolas Janus, et al.. (2009). Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 29(5). 492–494. 18 indexed citations
10.
Ayllón, J., Nicolas Janus, Vincent Launay‐Vacher, et al.. (2008). Anti-VEGF therapies, cancer and renal function. Journal of Clinical Oncology. 26(15_suppl). 16001–16001. 2 indexed citations
11.
Oudard, Stéphane, Eugéniu Banu, F. Scotté, et al.. (2005). Docetaxel versus mitoxantrone as first-line chemotherapy for hormone-refractory prostate cancer (HRPC) patients. A meta-analysis of 3-year overall survival results. Journal of Clinical Oncology. 23(16_suppl). 4634–4634. 8 indexed citations
12.
Banu, Eugéniu, F. Scotté, Asima Banu, et al.. (2004). Corrected area under serum hemoglobin curve (Hb c-AUC) as a predictor of maximal hemoglobin response after erythropoietin (rHuEpo) treatment in chemotherapy induced anemia patients. Journal of Clinical Oncology. 22(14_suppl). 9586–9586. 3 indexed citations
13.
Luján, Juán, P. Parrilla, R. Robles, et al.. (1995). Laparoscopic cholecystectomy in the treatment of acute cholecystitis.. PubMed. 181(1). 75–7. 45 indexed citations
14.
Mompeán, Juan, et al.. (1994). Laparoscopic versus open appendicectomy: A prospective assessment. British journal of surgery. 81(1). 133–135. 81 indexed citations
15.
Parrilla, P., J. Ayllón, Juán Luján, et al.. (1993). Timing of Operation in Acute Cholecystitis: Prospective Study of 375 Cases Divided into Three Series – Early, Delayed and Late Surgery. Digestive Surgery. 10(2). 72–77. 2 indexed citations
16.
Campos, Ricardo Robles, Pascual Parrilla Paricio, J. Ayllón, et al.. (1992). Choledochoscopy Reduces Unnecessary Papillary Surgery. Digestive Surgery. 9(3). 141–144. 1 indexed citations
17.
Campos, Ricardo Robles, et al.. (1992). Management of the perineal wound following abdominoperineal resection: prospective study of three methods. British journal of surgery. 79(1). 29–31. 31 indexed citations
18.
Campos, Ricardo Robles, Pascual Parrilla Paricio, José Luis Aguayo Albasini, et al.. (1990). Gastrointestinal Bezoars. Digestive Surgery. 7(1). 39–44. 144 indexed citations
19.
Campos, Ricardo Robles, Pascual Parrilla Paricio, Juan Mompeán, et al.. (1990). Has There Been a Decrease in the Incidence of Uncomplicated Gastroduodenal Peptic Ulcer Surgery?. Digestive Surgery. 7(1). 26–30. 3 indexed citations
20.
Albasini, José Luis Aguayo, et al.. (1988). [Correlation between size and number of biliary stones and acute pancreatitis].. PubMed. 74(5). 528–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026